IBK Securities

What IBK Securities does

IBK Securities (IBK투자증권) is a Seoul-based, full-service Korean securities firm operating as a subsidiary of Industrial Bank of Korea (IBK). Founded in 2008 with 501–1,000 employees, the firm provides investment banking services — including IPO underwriting and public-offering management — alongside equity research distribution and brokerage operations. Its client base spans corporate issuers seeking capital markets access (e.g., HL Genomics' KOSDAQ IPO) and institutional/retail investors consuming equity research with target-price guidance across Korean equities.

The firm's revenue model is transaction-fee based, generated through underwriting commissions on public offerings, brokerage fees on trading activity, and advisory mandates. IBK Securities has been active in 2026 deal flow, including co-leading the HL Genomics KOSDAQ IPO alongside KB Securities (targeting 47.5–55.1 billion won in fundraising) and issuing equity research with Buy/Sell recommendations on Samsung Electronics, Samsung C&T, and HS Hyosung Advanced Materials. Distribution is conducted through joint underwriting syndicates, institutional equity research distribution, and IPO roadshows targeting both institutional demand-forecast and general-subscription channels.

As a subsidiary of IBK, the firm benefits from parent-bank corporate relationships and brand credibility, which provide cross-selling opportunities and underwriting mandate flow. The technology stack is not publicly disclosed; no proprietary AI/ML capabilities, product modules, or platform architecture are documented in available sources. Detailed fee schedules and product-level economics are likewise not disclosed.

Name

IBK Securities

Legal name

IBK투자증권

Website

https://ibks.com

Company type

Private

Founded year

2008

Headcount range

501–1,000 employees

Short description

IBK Securities is a Seoul-based, full-service Korean securities firm and subsidiary of Industrial Bank of Korea, providing IPO underwriting, equity research, and brokerage services to corporate issuers and institutional/retail investors across Korean capital markets.

Ownership category

akta.pro rank

Product category

Securities Brokerage & Investment Banking

NAICS

Investment Banking and Securities Intermediation (52315)

SIC

Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Independent Broker-Dealers (Retail Network) (FSAAAAAC)

akta.pro secondary industries

Equity Capital Markets Advisory (Equity Issuance Strategy & Readiness) (FSACAAAI), Equity Research (FSACAGAA)

Keywords

• Investment banking services
• Equity research coverage
• IPO underwriting
• Securities brokerage
• Capital markets advisory

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Revenue model

1. Investment Banking / Underwriting: IBK Investment & Securities serves as a lead underwriter (jointly with KB Securities) for IPOs, earning fees on securities issuance and public offerings. For HL Genomics, the firm co-managed a public offering of 2,565,000 shares priced between 18,500 won and 21,500 won, targeting a fundraising range of 47.5 billion to 55.1 billion won.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

IBK Securities is a South Korean full-service securities firm that provides investment banking services, including IPO underwriting (e.g., serving as joint lead underwriter with KB Securities for KOSDAQ listings such as HL Genomics), and distributes equity research reports with target prices and Buy/Hold/Sell recommendations to institutional and retail investors across Korean equities. The firm operates as a subsidiary of Industrial Bank of Korea (IBK), leveraging the parent group's corporate relationships for capital markets transactions.

Product overview

IBK투자증권 (IBK Investment & Securities) is a Korean securities firm. Based on available source data, no specific product portfolio, modules, or named offerings were identified. The company appears as an underwriter in IPO transactions and issues investment research and target price recommendations, but detailed product information is not available in the provided sources.

Differentiator

Problem solved

Functional benefit

Products and services

• IPO Underwriting and Public Offering Management Lead or co-lead underwriting of IPOs and public offerings on Korean exchanges (KOSDAQ/KOSPI), including share pricing, institutional demand forecasting, and general subscription management. Serves corporate issuers seeking to list and raise public capital.

Named customers4 records

Segments2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• KB SecuritiescoreChannel Partner/ Reseller/ DistributorIBK Investment & Securities and KB Securities are co-lead underwriters for HL Genomics' KOSDAQ IPO, managing the public offering of 2,565,000 shares priced between 18,500 won and 21,500 won, targeting a fundraising range of 47.5 billion to 55.1 billion won. This joint underwriting arrangement is standard practice in Korean capital markets for distributing IPO risk and expanding investor reach.

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Hi Investment & Securities: Hi Investment & Securities is a Korean securities firm providing investment banking, brokerage, and research. It is a comparable mid-tier peer to IBK Securities in Korean ECM and equity research.
• KB Securities: KB Securities is a major Korean full-service securities firm and a co-lead underwriter with IBK Securities on the HL Genomics KOSDAQ IPO. It directly competes in ECM, brokerage, and research in the Korean market.
• Meritz Securities: Meritz Securities is a Korean full-service securities firm with strong ECM and trading capabilities. It is a direct peer to IBK Securities in underwriting Korean IPOs/follow-ons and brokerage execution.
• Eugene Investment & Securities: Eugene Investment & Securities is a mid-sized Korean securities firm offering investment banking and brokerage services, competing with IBK Securities for Korean ECM mandates and retail/institutional brokerage.

Broad incumbents

• Shinhan Investment: Shinhan Investment is a Korean securities firm affiliated with Shinhan Financial Group, providing investment banking, brokerage, and equity research, competing with IBK Securities across Korean institutional and retail channels.
• Samsung Securities: Samsung Securities is a leading Korean securities firm with full-service investment banking, brokerage, and trading operations, competing directly with IBK Securities in underwriting and equity research on Korean large-cap names.
• Korea Investment & Securities: Korea Investment & Securities is a top-tier Korean securities firm providing investment banking, brokerage, and asset management services. It is one of IBK Securities' principal competitors in the Korean ECM and brokerage market.
• Hana Financial Investment: Hana Financial Investment is a bank-affiliated Korean securities firm offering investment banking, brokerage, and research services, operating in the same domestic ECM and equity research segments as IBK Securities.
• Mirae Asset Securities: Mirae Asset Securities is one of the largest Korean securities firms, offering investment banking, brokerage, and wealth management with a broader product set and larger balance sheet than IBK Securities, competing across ECM and trading.
• NH Investment & Securities: NH Investment & Securities is a major Korean broker-dealer affiliated with NongHyup Bank, offering investment banking, brokerage, and research across Korean equities, directly overlapping with IBK Securities' segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ibk-securities

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments30 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IBK Securities